clebopride maleate

Small moleculeexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Mechanism of action

  • HTR4 agonist

    Clebopride, a D-2 dopamine antagonist with antiemetic and prokinetic properties, can improve the bowel cleansing efficacy. Clebopride also stimulates peripheral 5-HT4 receptors and shortens intestinal transit time.

    A receptor binding assay revealed that clebopride bound to the D2 dopamine receptor with a high affinity and to the alpha-2 adrenoceptor and 5-HT2 serotonin receptor with relatively lower affinity, and not to D1 dopamine, alpha-1 adrenergic, muscarinic acetylcholine, H1 histamine, or opioid receptor.

  • DRD2 antagonist

    Clebopride, a D-2 dopamine antagonist with antiemetic and prokinetic properties, can improve the bowel cleansing efficacy. Clebopride also stimulates peripheral 5-HT4 receptors and shortens intestinal transit time.

    A receptor binding assay revealed that clebopride bound to the D2 dopamine receptor with a high affinity and to the alpha-2 adrenoceptor and 5-HT2 serotonin receptor with relatively lower affinity, and not to D1 dopamine, alpha-1 adrenergic, muscarinic acetylcholine, H1 histamine, or opioid receptor.

Chemistry & pharmacology

Loading structure…

SMILES

COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1
Mol. weight
373.88 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • clanzoflat
  • clebopride
  • clebopride
  • clebopride
  • clebopride
  • clebopride
  • clebopride
  • clebopride fumarate (1:1)
  • clebopride malate
  • clebopride malate
  • clebopride maleate
  • clebopride maleate
  • clebopride maleate (1:1)
  • clebopride mono-hydrochloride
  • cleboril
  • cleboril
  • cleboril
  • las-9273
  • las-9273
  • n-1-benzyl-4 piperidil-3-methoxy-4-amino-5-chlorobenzamide
  • n-(1'-benzyl-4'-piperidyl)-2-methoxy-4-amino-5- chlorobenzamide